US pharmaceutical firms’ international redeployment strategies, entry modes, and performance outcomes

Xu, Mingrui

Permalink

https://hdl.handle.net/2142/121323 Copy

Description

Title

US pharmaceutical firms’ international redeployment strategies, entry modes, and performance outcomes

Author(s)

Xu, Mingrui

Issue Date

2023-06-30

Director of Research (if dissertation) or Advisor (if thesis)

Mahoney, Joseph T.

Doctoral Committee Chair(s)

• Mahoney, Joseph T.
• Yao, Fiona Kun

Committee Member(s)

• Sakhartov, Arkadiy
• Schijven, Mario

Department of Study

Business Administration

Discipline

Business Administration

Degree Granting Institution

University of Illinois at Urbana-Champaign

Degree Name

Ph.D.

Degree Level

Dissertation

Keyword(s)

• Redeployability
• Resource redeployment
• Entry mode
• Expatriate staffing
• Pharmaceutical industry

Abstract

This dissertation provides three empirical studies investigating multinational enterprises’ (MNEs) entry mode decisions, performance outcomes of the sequential moves of divestitures and subsequent greenfield investments, and expatriate staffing, respectively. From the redeployability perspective, all three empirical studies explore how MNEs’ sequential decision-making may help modify their resource base to improve performance and secure competitive advantage. With the context of US pharmaceutical firms’ global investments, this dissertation seeks to connect the redeployability perspective with international business (IB) phenomena and thus provide more empirical evidence for this value-creation mechanism through which firms free up and redeploy resources across countries. In addition, this dissertation examines potential boundary conditions for the redeployability perspective in IB research.

Graduation Semester

2023-08

Type of Resource

Thesis

Handle URL

https://hdl.handle.net/2142/121323

Copyright and License Information

Copyright 2023 Mingrui Xu

Owning Collections